First findings from Project Twenty 21 unveiled

Initial findings from Project Twenty 21, the UK’s largest medicinal cannabis patient study, indicate the treatment dramatically improves quality of life for people with life-limiting conditions including chronic pain, multiple sclerosis, tourette’s syndrome, epilepsy and post traumatic stress disorder.

The study has now licensed medical cannabis prescriptions to more than 900 patients in substantially poorer health than the general population, and who have been unable to manage their diagnosed conditions with commonly prescribed medicines.